Dashboard
Manage Tickers

ADIL ADIAL PHARMACEUTICALS, INC.

Nasdaq adialpharma.com


$ 0.33 $ 0.00 (0 %)    

Friday, 14-Nov-2025 08:39:08 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 600.23 $ 0.00 (0 %)
DIA $ 471.77 $ 0.00 (0 %)
SPY $ 666.05 $ 0.00 (0 %)
TLT $ 89.74 $ 0.00 (0 %)
GLD $ 373.32 $ 0.00 (0 %)
$ 0.319
$ 0.32
$ 0.31 x 72
$ 0.32 x 100
-- - --
$ 0.22 - $ 1.30
215,001
na
7.07M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-13-2025 06-30-2025 10-Q
3 05-14-2025 03-31-2025 10-Q
4 03-04-2025 01-01-1970 10-K
5 11-13-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 04-01-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-21-2023 06-30-2023 10-Q
11 05-12-2023 03-31-2023 10-Q
12 03-30-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-13-2022 06-30-2022 10-Q
15 05-13-2022 03-31-2022 10-Q
16 03-28-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-17-2021 03-31-2021 10-Q
20 03-22-2021 12-31-2020 10-K
21 11-13-2020 09-30-2020 10-Q
22 08-13-2020 06-30-2020 10-Q
23 05-14-2020 03-31-2020 10-Q
24 03-20-2020 12-31-2019 10-K
25 11-14-2019 09-30-2019 10-Q
26 08-13-2019 06-30-2019 10-Q
27 05-13-2019 03-31-2019 10-Q
28 02-19-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 09-10-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

adial-pharmaceuticals-q3-net-loss-18m
Adial Pharmaceuticals Q3 Net Loss $1.8M
11/14/2025 13:39:49

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
11/12/2025 21:05:55

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/24/2025 12:07:33

adial-pharma-completes-analytical-validation-of-cheek-swab-collection-method-for-testing-patients-for-both-clinical-trial-usage-as-well-as-future-commercial-application
Adial Pharma Completes Analytical Validati...
10/09/2025 12:40:34

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical compan...

this-semtech-analyst-turns-bullish-here-are-top-5-upgrades-for-tuesday
This Semtech Analyst Turns Bullish; Here A...
09/30/2025 15:26:25

maxim-group-upgrades-adial-pharmaceuticals-to-buy-announces-15-price-target
Maxim Group Upgrades Adial Pharmaceuticals...
09/30/2025 12:32:16

Maxim Group analyst Jason McCarthy upgrades Adial Pharmaceuticals (NASDAQ:ADIL) from Hold to Buy and announces $1.5 price ta...

adial-pharmaceuticals-highlights-favorable-comments-from-fda-meeting-for-lead-program-in-alcohol-use-disorder
Adial Pharmaceuticals Highlights Favorable...
09/16/2025 12:03:43

Adial Pharmaceuticals received FDA backing for its Phase 3 AD04 trial, including endpoints and strategies for targeted populati...

adial-pharma-receives-180-day-nasdaq-extension-to-regain-minimum-bid-price-compliance
Adial Pharma Receives 180-Day Nasdaq Exten...
09/03/2025 12:42:36

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical compan...

adial-pharma-highlights-us-senate-backing-for-expanded-aud-trial-endpoints-reinforcing-ad04-development-strategy-focused-on-craving-reduction
Adial Pharma Highlights U.S. Senate Backin...
08/20/2025 12:41:07

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical compan...

adial-pharmaceuticals-q2-eps-018-beats-025-estimate
Adial Pharmaceuticals Q2 EPS $(0.18) Beats...
08/13/2025 21:43:08

Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of...

whats-driving-the-market-sentiment-around-adial-pharmaceuticals
What's Driving the Market Sentiment Around...
08/13/2025 16:00:26

adial-pharmaceuticals-completes-end-of-phase-2-meeting-with-fda-for-ad04-phase-3-trial-design-and-program
Adial Pharmaceuticals Completes End of Pha...
08/06/2025 12:04:29

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
08/04/2025 12:08:38

why-commscope-shares-are-trading-higher-by-around-40-here-are-20-stocks-moving-premarket
Why CommScope Shares Are Trading Higher By...
08/04/2025 10:55:34

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/01/2025 21:06:34

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
07/28/2025 21:05:57

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
07/28/2025 17:06:06

adial-pharmaceuticals-regains-nasdaq-compliance
Adial Pharmaceuticals Regains Nasdaq Compl...
07/16/2025 12:35:53

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/10/2025 21:05:48

adial-pharmaceuticals-files-pct-patent-application-to-extend-ip-exclusivity-on-core-technology-to-at-least-2045
Adial Pharmaceuticals Files PCT Patent App...
07/09/2025 12:37:21

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION